Geographic variation in the second-line treatment of non-small cell lung cancer.
about
KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancerIncreased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan.Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
P2860
Geographic variation in the second-line treatment of non-small cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Geographic variation in the second-line treatment of non-small cell lung cancer.
@ast
Geographic variation in the second-line treatment of non-small cell lung cancer.
@en
type
label
Geographic variation in the second-line treatment of non-small cell lung cancer.
@ast
Geographic variation in the second-line treatment of non-small cell lung cancer.
@en
prefLabel
Geographic variation in the second-line treatment of non-small cell lung cancer.
@ast
Geographic variation in the second-line treatment of non-small cell lung cancer.
@en
P2093
P1433
P1476
Geographic variation in the second-line treatment of non-small cell lung cancer.
@en
P2093
Ikuo Sekine
Martin J Edelman
Nagahiro Saijo
Tomohide Tamura
P304
P356
10.1053/J.SEMINONCOL.2005.12.003
P433
P577
2006-02-01T00:00:00Z